Teriparatide0 vendors competing
No vendor pricing available for this peptide yet.
Research details
Teriparatide — research data
Regulatory statusFDA-approved (Forteo)
NCAA D1Not listed
Overview
About Teriparatide
Mechanism of action
Recombinant PTH 1-34; anabolic bone building through osteoblast stimulation and activation
Safety profile
Orthostatic hypotension, leg cramps, osteosarcoma risk (black box warning) · Approved for osteoporosis; 2-year limit (animal osteosarcoma); well-characterized in humans
Related pages